University of Michigan ( Site 0009) — Ann Arbor, Michigan

University of Michigan ( Site 0009) is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Michigan ( Site 0009) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan ( Site 0009)?

University of Michigan ( Site 0009) has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan ( Site 0009) conducted?

University of Michigan ( Site 0009) has 2 clinical trials on record, with 2 currently active. Their work covers Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.

Is University of Michigan ( Site 0009) accredited by Crixeo Health?

University of Michigan ( Site 0009) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan ( Site 0009)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.